MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
Public ClinicalTrials.gov record NCT06212466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Myocardial Ischemia With No Obstructive Coronary Artery Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, multicenter, observational, single-arm trial to validate CardioFlux MCG's ability to diagnose myocardial ischemia caused by coronary microvascular dysfunction in patients with suspected ischemia and confirmed no obstructive coronary artery disease (suspected INOCA) by using diagnostic measures of coronary flow reserve (CFR) via invasive angiography as a reference standard for diagnosis.
Study identification
- NCT ID
- NCT06212466
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 136 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 3, 2024 (Actual)
- Primary completion
- Apr 15, 2025 (Actual)
- Completion
- Apr 15, 2025 (Actual)
- Last update posted
- Jul 10, 2025
2024 – 2025
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Florida, Division of Cardiovascular Medicine | Gainesville | Florida | 32610 | — |
| Saint Elizabeth Medical Center | Edgewood | Kentucky | 41017 | — |
| Ascension St. John Hospital | Detroit | Michigan | 48236 | — |
| Mayo Clinic, Cardiovascular Research | Rochester | Minnesota | 55905 | — |
| St. Luke's Health System, Cardiovascular Research | Kansas City | Missouri | 64111 | — |
| Hackensack Meridian Mountainside Medical Center | Montclair | New Jersey | 07042 | — |
| The Christ Hospital | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic, Cardiovascular Medicine Research | Cleveland | Ohio | 44195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06212466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06212466 live on ClinicalTrials.gov.